Symbol
DNA on NYSE
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
13,157,694 shares
Security Ownership %
6.6%
Shares, Excluding Options vs Price
Value, Excluding Options

BAILLIE GIFFORD & CO ownership in RECURSION PHARMACEUTICALS, INC. Common Stock (DNA)

12 Feb 2025 - BAILLIE GIFFORD & CO has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,157,694 shares of RECURSION PHARMACEUTICALS, INC. Common Stock (DNA). This represents 6.6% ownership of the company. In their previous filing dated 05 Nov 2024, BAILLIE GIFFORD & CO had reported owning 15,570,335 shares, indicating a decrease of +15%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.